CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-26 | Cohen Fred E Director | Grant or award | +69,339 | $9.54 | $661K | 69,339 |
| 2023-07-25 | Robinson James A. Jr. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-25 | Robinson James A. Jr. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-06-08 | Schoenberg Mark Chief Medical Officer | Grant or award · Restricted Stock Units | +30,000 | 30,000 | ||
| 2023-01-31 | Barrett Elizabeth A. Chief Executive Officer | Option exercise | +5,000 | 313,358 | ||
| 2023-01-31 | Barrett Elizabeth A. Chief Executive Officer | Option exercise | +13,333 | 326,691 | ||
| 2023-01-31 | Barrett Elizabeth A. Chief Executive Officer | Option exercise · Restricted Stock Units | −5,000 | 0 | ||
| 2023-01-31 | Barrett Elizabeth A. Chief Executive Officer | Option exercise · Restricted Stock Units | −13,333 | 13,334 | ||
| 2023-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2023-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Performance Stock Units | +100,000 | 100,000 | ||
| 2023-01-31 | Kim Dong Chief Financial Officer | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2023-01-31 | Kim Dong Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2023-01-31 | Smith Jason Drew General Counsel | Option exercise | +833 | 13,009 | ||
| 2023-01-31 | Smith Jason Drew General Counsel | Sale | −409 | $10.12 | $4K | 12,600 |
| 2023-01-31 | Smith Jason Drew General Counsel | Option exercise | +2,500 | 15,100 | ||
| 2023-01-31 | Smith Jason Drew General Counsel | Sale | −1,227 | $10.12 | $12K | 13,873 |
| 2023-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −833 | 834 | ||
| 2023-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −2,500 | 5,000 | ||
| 2023-01-31 | Smith Jason Drew General Counsel | Grant or award · Restricted Stock Units | +20,000 | 20,000 |
Page 10 of 13 · 244 trades